Israel Englander Clovis Oncology, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $4.65 Million - $12.6 Million	-4,423,940 Reduced 81.92%	976,384 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $1.13 Million - $5.32 Million	1,798,313 Added 49.93%	5,400,324 $9.72 Million
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $3.61 Million - $7.93 Million	2,525,471 Added 234.59%	3,602,011 $7.28 Million
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $1.33 Million - $2.34 Million	492,367 Added 84.28%	1,076,540 $2.92 Million
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $6.98 Million - $9.98 Million	-1,720,201 Reduced 74.65%	584,173 $2.61 Million
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $400,445 - $562,378	79,770 Added 3.59%	2,304,374 $13.4 Million
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $6.42 Million - $13.8 Million	1,335,581 Added 150.23%	2,224,604 $15.6 Million
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $3.17 Million - $4.92 Million	767,531 Added 631.75%	889,023 $4.27 Million
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $522,618 - $837,056	-108,427 Reduced 47.16%	121,492 $708,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $1.31 Million - $2.23 Million	229,919 New	229,919 $1.55 Million
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $1.19 Million - $6.49 Million	-395,237 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $489,391 - $1.91 Million	124,527 Added 46.0%	395,237 $1.55 Million
Q2 2019 Aug 15, 2019	SELL	$12.81 - $25.67 $22.1 Million - $44.3 Million	-1,726,613 Reduced 86.45%	270,710 $4.03 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $25 Million - $50.1 Million	1,951,199 Added 4230.33%	1,997,323 $5.79 Million
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $300,484 - $515,214	17,015 Added 58.45%	46,124 $1.15 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $244,090 - $685,677	20,988 Added 258.44%	29,109 $523,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $238,513 - $401,827	8,121 New	8,121 $239,000
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $10.4 Million - $15.5 Million	-248,377 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $562,095 - $759,479	-11,215 Reduced 4.32%	248,377 $13.1 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $15 Million - $22 Million	259,592	259,592 $17.7 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account